Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimpy P Shah

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|January 10, 2012
Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancerDimpy P Shah, Katia K El Taoum, Jharna N Shah, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 9, 2018
Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignanciesErik Vakil, Ajay Sheshadri, Saadia A Faiz, et al.
Cancer Cell|April 24, 2021
Care without a compass: Including patients with cancer in COVID-19 studiesChristopher R Friese, Toni K Choueiri, Narjust Duma, et al.
Vaccines|April 25, 2020
Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) RecipientsXunyan Ye, Wanderson Cabral de Rezende, Obinna Patrick Iwuchukwu, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infectionsDimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
The Journal of Infectious Diseases|January 25, 2018
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant RecipientsXunyan Ye, Obinna P Iwuchukwu, Vasanthi Avadhanula, et al.
BMC Microbiology|January 15, 2021
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome samplingMeghan I Short, Robert Hudson, Benjamin D Besasie, et al.
Blood|April 5, 2014
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsDimpy P Shah, Shashank S Ghantoji, Ella J Ariza-Heredia, et al.
Frontiers in Immunology|April 16, 2019
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation AdultsXunyan Ye, Obinna P Iwuchukwu, Vasanthi Avadhanula, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|January 10, 2012
Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancerDimpy P Shah, Katia K El Taoum, Jharna N Shah, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 9, 2018
Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignanciesErik Vakil, Ajay Sheshadri, Saadia A Faiz, et al.
Cancer Cell|April 24, 2021
Care without a compass: Including patients with cancer in COVID-19 studiesChristopher R Friese, Toni K Choueiri, Narjust Duma, et al.
Vaccines|April 25, 2020
Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) RecipientsXunyan Ye, Wanderson Cabral de Rezende, Obinna Patrick Iwuchukwu, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infectionsDimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
The Journal of Infectious Diseases|January 25, 2018
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant RecipientsXunyan Ye, Obinna P Iwuchukwu, Vasanthi Avadhanula, et al.
BMC Microbiology|January 15, 2021
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome samplingMeghan I Short, Robert Hudson, Benjamin D Besasie, et al.
Blood|April 5, 2014
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsDimpy P Shah, Shashank S Ghantoji, Ella J Ariza-Heredia, et al.
Frontiers in Immunology|April 16, 2019
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation AdultsXunyan Ye, Obinna P Iwuchukwu, Vasanthi Avadhanula, et al.
Pageof 8